Commitments and Contingencies

9 Months Ended

Jun. 30, 2025

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

COMMITMENTS AND CONTINGENCIES

Litigation

From time to time, the Company may be subject to various claims and legal proceedings in the ordinary course of business. If the potential loss from any claim, asserted or unasserted, or legal proceeding is considered probable and the amount is reasonably estimable, the Company will accrue a liability for the estimated loss. There were no contingent liabilities recorded as of June 30, 2025.

Commitments

The Company owns land in the Verona Technology Park in Verona, Wisconsin, where it has constructed an approximately 160,000 square foot drug manufacturing facility and an approximately 140,000 square foot laboratory and office facility to support manufacturing process development and analytical activities.

As of June 30, 2025, the build-out of these facilities was substantially completed, with total costs incurred of $293.2 million. These costs included (i) $76.0 million capitalized to building, related to the laboratory and office facility, and (ii) $11.5 million capitalized to research equipment, $173.3 million capitalized to building, $16.5 million capitalized to manufacturing equipment, and $15.9 million in construction in progress, related to the drug manufacturing facility. The Company has an expected outstanding balance of approximately $3.3 million remaining to be settled.